Profil
Eyal Rubin is Chief Financial Officer & Executive Vice President at Nasus Pharma Ltd. since 2025.
Former roles include CFO, Secretary, Treasurer & Senior Vice President at Protalix Biotherapeutics, Inc. from 2019 to 2025; Chief Financial Officer, Treasurer & Executive VP at Brainstorm Cell Therapeutics, Inc. from 2017 to 2019; Vice President & Head-Treasury at Teva Pharmaceutical Industries Ltd. from 2013 to 2017; Head-Finance & Banking Department at Cellcom Israel Ltd. from 2010 to 2013; Chief Financial Officer at Idt Carmel, Inc. from 2006 to 2010; Chief Financial Officer & General Manager at V-Secure Technologies, Inc. from 2003 to 2005; Chief Operating Officer & Vice President-Finance at Sec2Wireless, Inc. from 1999 to 2003.
Education includes an MBA from Bar-Ilan University and an undergraduate degree from The College of Management Academic Studies.
Aktive Positionen von Eyal Rubin
| Unternehmen | Position | Beginn |
|---|---|---|
| NASUS PHARMA LTD. | Finanzdirektor/CFO | 20.11.2025 |
Ehemalige bekannte Positionen von Eyal Rubin
| Unternehmen | Position | Ende |
|---|---|---|
| PROTALIX BIOTHERAPEUTICS, INC. | Finanzdirektor/CFO | 24.08.2025 |
| BRAINSTORM CELL THERAPEUTICS INC. | Finanzdirektor/CFO | 06.09.2019 |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Officer/Principal | 01.01.2017 |
| CELLCOM ISRAEL LTD. | Corporate Officer/Principal | 01.03.2013 |
Idt Carmel, Inc. | Finanzdirektor/CFO | 01.01.2010 |
Ausbildung von Eyal Rubin
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd. Pharmaceuticals: GenericHealth Technology Manufactures and markets generic and proprietary branded pharmaceuticals and active pharmaceutical ingredients | Health Technology |
Brainstorm Cell Therapeutics, Inc.
Brainstorm Cell Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company, which develops innovative adult stem cell therapeutic products | Health Technology |
Sec2Wireless, Inc.
Sec2Wireless, Inc. Miscellaneous Commercial ServicesCommercial Services Develops user authentication and monitoring security solutions | Commercial Services |
Cellcom Israel Ltd.
Cellcom Israel Ltd. Wireless TelecommunicationsCommunications Provides cellular communications services | Communications |
Bar-Ilan University
Bar-Ilan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
V-Secure Technologies, Inc.
V-Secure Technologies, Inc. Computer PeripheralsElectronic Technology V-Secure Technologies, Inc. develops network security solutions. Its patent-pending technology utilizes adaptive, behavior-based, and closed-loop filtering. The company was founded by Avner Barak and Roni Goldberg and is headquartered in Saddle Brook, NJ. | Electronic Technology |
Protalix Biotherapeutics, Inc.
Protalix Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets recombinant therapeutic proteins | Health Technology |
The College of Management Academic Studies
The College of Management Academic Studies Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Idt Carmel, Inc. | |
Nasus Pharma Ltd.
Nasus Pharma Ltd. Pharmaceuticals: MajorHealth Technology Operates as a drug delivery company that develops powder-based intranasal products | Health Technology |
















